WHO 2004 Criteria and CK19 are Reliable Prognostic Markers in Pancreatic Endocrine Tumors-Reference-Cited by-同舟云学术

WHO 2004 Criteria and CK19 are Reliable Prognostic Markers in Pancreatic Endocrine Tumors

Published:2007-11 Issue:11 Volume:31 Page:1677-1682
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Schmitt Anja M.,Anlauf Martin,Rousson Valentin,Schmid Sonja,Kofler Andreas,Riniker Florian,Bauersfeld Juliane,Barghorn Andre,Probst-Hensch Nicole M.,Moch Holger,Heitz Philipp U.,Kloeppel Guenter,Komminoth Paul,Perren Aurel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference19 articles.

1. The predictive value of CK19 and CD99 in pancreatic endocrine tumors;Ali;Am J Surg Pathol,2006

2. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome;Anlauf;Am J Surg Pathol,2006

3. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies;Bubendorf;J Pathol,2001

4. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior;Canavese;Hum Pathol,2001

5. Revised classification of neuroendocrine tumors of the lung, pancreas and gut;Capella;Digestion,1994

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors;International Journal of Molecular Sciences;2024-09-03

2. Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors;Endocrine Pathology;2022-12-24

3. Multimodal 3-D/2-D human islet and duct imaging in exocrine and endocrine lesion environment: associated pancreas tissue remodeling;American Journal of Physiology-Endocrinology and Metabolism;2022-10-01

4. Cytokeratin 19;Endocrine Pathology;2022

5. Biomarkers for prognosis in pancreatic neuroendocrine tumors;Endocrine-Related Cancer;2021-12-01